Marcel Bühler is a postdoctoral researcher at the VIB-UGent Center for Medical Biotechnology and a doctor-assistant at the Department of Biomolecular Medicine, Ghent University. He earned his PhD in Cancer Biology from the University of Zurich in 2023, where he specialized in longitudinal proteomic profiling of glioblastoma using advanced mass spectrometry techniques. His current research focuses on the development and application of single-cell proteomics workflows to study cellular heterogeneity in health and disease, particularly in cancers such as melanoma and lung cancer. Dr. Bühler is also involved in collaborative projects in reproductive biology, including studies on proteomic markers of fertility. He is an active member of the Cancer Research Institute Ghent (CRIG) and the Single-Cell Network Ghent (SING), contributing to the integration of cutting-edge proteomic technologies in biomedical research.
Marcel Bühler is a postdoctoral researcher at the VIB-UGent Center for Medical Biotechnology and a doctor-assistant at the Department of Biomolecular Medicine, Ghent University. He earned his PhD in Cancer Biology from the University of Zurich in 2023, where he specialized in longitudinal proteomic profiling of glioblastoma using advanced mass spectrometry techniques. His current research focuses on the development and application of single-cell proteomics workflows to study cellular heterogeneity in health and disease, particularly in cancers such as melanoma and lung cancer. Dr. Bühler is also involved in collaborative projects in reproductive biology, including studies on proteomic markers of fertility. He is an active member of the Cancer Research Institute Ghent (CRIG) and the Single-Cell Network Ghent (SING), contributing to the integration of cutting-edge proteomic technologies in biomedical research.